A Clinical Study to test and Compare the efficacy of Shadushana Guggulu with Udvartana in Sthoulya (Primary Obesity), with the efficacy of Navaka Guggulu with Udvartana

A randomized open labelled clinical study on the efficacy of Shadushana Guggulu with Udvartana in Sthoulya with specical refernce to primary obesity and its comparision with the efficacy of Navaka Guggulu with Udvartana - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103982

Enrollment

Registered

2026-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects between the age group of 20 -50 years irrespective of gender, religion, occupation and socio-economic status. Subjects fulfilling diagnostic criteria. Subjects who are willing to give a written consent for the treatment, that is conveyed in the local language in which subject can understand.

Exclusion criteria

Exclusion criteria: Subject diagnosed with Secondary Obesity that are due to Hypothyrodism, Diabetes Mellitus and any other medical conditions that leads to Secondary Obesity. Pregnant and lactating women. Subjects suffering from uncontrolled systemic illness like Hypertension, Cardiovascular diseases, Diabetes Mellitus and on prolonged concurrent medications which intervene with the course of disease and course of treatment.

Design outcomes

Primary

Measure	Time frame
1.Assessment of Significant changes will be made on basis of grading and scoring of the subjective parameters like Dourbalya, Sveda Pradhurbhava,Atikshudhata ,Trishna, Nidradhikya and Objective parameters like BMI and Anthropometric measurements. 2.Establishment of Clinical Efficacy of Administration Shadushana Guggulu with Udvartana in SthoulyaTimepoint: Group A Triphala Choorna Udvartana with Shadushana Guggulu (Trial group). Group B Triphala choorna Udvartana with Navaka Guggulu (Comparitive group). Trial period: 30 days. Drug free follow up: 30 days. Total study duration: 60 days. Assesments will be done on 0th day, 8th day, 31st day and 60th day for both Trial and Comparitive group	—

Measure

Time frame

1.Assessment of Significant changes will be made on basis of grading and scoring of the subjective parameters like Dourbalya, Sveda Pradhurbhava,Atikshudhata ,Trishna, Nidradhikya and Objective parameters like BMI and Anthropometric measurements. 2.Establishment of Clinical Efficacy of Administration Shadushana Guggulu with Udvartana in SthoulyaTimepoint: Group A Triphala Choorna Udvartana with Shadushana Guggulu (Trial group). Group B Triphala choorna Udvartana with Navaka Guggulu (Comparitive group). Trial period: 30 days. Drug free follow up: 30 days. Total study duration: 60 days. Assesments will be done on 0th day, 8th day, 31st day and 60th day for both Trial and Comparitive group

—

Secondary

Measure	Time frame
1.Generation of data on Significant changes observed in the grading & scoring in Subjective & Objective parameters. 2.Generation of data on possible unexpected or adverse drug reactions or events. 3. Generation in depth ananlysis data on different aspect of the disease.Timepoint: Group A Triphala Choorna Udvartana with Shadushana Guggulu (Trial group). Group B Triphala choorna Udvartana with Navaka Guggulu (Comparitive group). Trial period: 30 days. Drug free follow up: 30 days. Total study duration: 60 days. Assesments will be done on 0th day, 8th day, 31st day & 60th day for both Trial & Comparitive group	—

Measure

Time frame

1.Generation of data on Significant changes observed in the grading & scoring in Subjective & Objective parameters. 2.Generation of data on possible unexpected or adverse drug reactions or events. 3. Generation in depth ananlysis data on different aspect of the disease.Timepoint: Group A Triphala Choorna Udvartana with Shadushana Guggulu (Trial group). Group B Triphala choorna Udvartana with Navaka Guggulu (Comparitive group). Trial period: 30 days. Drug free follow up: 30 days. Total study duration: 60 days. Assesments will be done on 0th day, 8th day, 31st day & 60th day for both Trial & Comparitive group

—

Countries

India

Contacts

Public ContactDr Sowmyashree U P

Sri Sri College Of Ayurvedic Science And Research Hospital

sowmyanaveenbs@gmail.com8618716570

Outcome results